GlassScriptPhysician profile
Kevin Wayne Mcconnell
NPI 1467455998
$19,507.64
in general payments reported to CMS, 2019-2025
36 companies · $838 in 2025
The $838 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,076 · 2020: $1,018 · 2021: $3,631 · 2022: $2,631 · 2023: $6,200 · 2024: $1,114 · 2025: $838.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,680 · Education: $3,026 · Travel and Lodging: $1,430 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,679.98 |
| Education | $3,025.89 |
| Travel and Lodging | $1,429.98 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,226.79 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $3,633.29 | 2020-2024 | Phasix Mesh |
| The Institute of Musculoskeletal Science and Education | $2,534.26 | 2019 | |
| Zimmer Biomet Holdings, INC. | $2,337.10 | 2019-2023 | Advantagerib |
| Tela Bio, INC. | $1,196.67 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Ethicon US, LLC | $1,007.09 | 2019-2025 | Vistaseal, Dermabond Prineo, Evarrest |
| Stryker Corporation | $804.95 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $249.32 | 2020-2025 | Gattex |
| Csl Behring | $159.13 | 2019-2025 | Kcentra |
| Baxter Healthcare | $149.06 | 2019-2020 | |
| Hologic Sales and Service, LLC | $147.75 | 2024 | Coolseal Generator |
| Atricure, INC. | $143.98 | 2023-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Kerecis Limited | $105.31 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Abbvie INC. | $102.82 | 2021-2024 | |
| Kls-Martin L.P. | $78.88 | 2019-2024 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $76.20 | 2021-2025 | Novosorb Btm |
| Integra Lifesciences Corporation | $65.93 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| W. L. Gore & Associates, INC. | $58.45 | 2023-2025 | Gore Synecor Biomaterial, Gore Bio-A Tissue Reinforcement |
| Conmed Corporation | $50.00 | 2023 | Airseal |
| Innocoll Pharmaceuticals Limited | $49.10 | 2021 | |
| Boston Scientific Corporation | $40.99 | 2024 | Watchman Flx |
| Acera Surgical, INC. | $38.91 | 2024 | Restrata Wound Matrix |
| Vertex Pharmaceuticals Incorporated | $25.73 | 2025 | |
| Depuy Synthes Sales INC. | $23.55 | 2021 | |
| Innovation Technologies INC | $23.16 | 2025 | Irrisept |
| Aimmune Therapeutics, INC. | $19.21 | 2024 | |
| Z-Medica, LLC | $18.99 | 2019 | |
| Bsn Medical INC | $18.79 | 2025 | |
| Ambu INC. | $18.24 | 2024 | |
| Kci USA, INC. | $17.69 | 2023 | V.A.C. Veraflo Cleanse Choice |
| Convatec INC. | $16.12 | 2024 | |
| Organogenesis INC. | $14.87 | 2024 | Puraply Am |
| Melinta Therapeutics, LLC | $14.81 | 2019 | |
| Allergan, INC. | $14.13 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.39 | 2024 | Andexxa |
| Medtronic, INC. | $12.98 | 2023 | Dextile |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Mcconnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.